{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:15:31Z","timestamp":1787242531803,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871256"],"award-info":[{"award-number":["81871256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00253-021-11115-2","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T05:06:58Z","timestamp":1611551218000},"page":"1365-1377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cyclophilin A: a key player for etiological agent infection"],"prefix":"10.1007","volume":"105","author":[{"given":"Yating","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1820-746X","authenticated-orcid":false,"given":"Yanhua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"11115_CR1","doi-asserted-by":"publisher","unstructured":"Baugh JM, Garcia-Rivera JA, Gallay PA (2013) Host-targeting agents in the treatment of hepatitis C: a beginning and an end? Antivir Res 100(2):555\u2013561. https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.020","DOI":"10.1016\/j.antiviral.2013.09.020"},{"key":"11115_CR2","doi-asserted-by":"publisher","unstructured":"Bose S, Mathur M, Bates P, Joshi N, Banerjee AK (2003) Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. J Gen Virol 84(Pt 7):1687\u20131699. https:\/\/doi.org\/10.1099\/vir.0.19074-0","DOI":"10.1099\/vir.0.19074-0"},{"key":"11115_CR3","unstructured":"Browning GF, Noormohammadi AH, Markham PF (2014) Identification and Characterization of Virulence Genes in Mycoplasmas. In: Browning GF, Citti C (eds) Mollicutes: molecular biology and pathogenesis. Norfolk, UK,\u00a0pp 77\u201390"},{"key":"11115_CR4","doi-asserted-by":"publisher","unstructured":"Burse M, Shi J, Aiken C (2017) Cyclophilin A potentiates TRIM5\u03b1 inhibition of HIV-1 nuclear import without promoting TRIM5\u03b1 binding to the viral capsid. PLoS One 12(8):e0182298. https:\/\/doi.org\/10.1371\/journal.pone.0182298","DOI":"10.1371\/journal.pone.0182298"},{"key":"11115_CR5","doi-asserted-by":"publisher","unstructured":"Carbajo-Lozoya J, Muller MA, Kallies S, Thiel V, Drosten C, von Brunn A (2012) Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res 165(1):112\u2013117. https:\/\/doi.org\/10.1016\/j.virusres.2012.02.002","DOI":"10.1016\/j.virusres.2012.02.002"},{"key":"11115_CR6","doi-asserted-by":"publisher","unstructured":"Carbajo-Lozoya J, Ma-Lauer Y, Malesevic M, Theuerkorn M, Kahlert V, Prell E, von Brunn B, Muth D, Baumert TF, Drosten C, Fischer G, von Brunn A (2014) Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. Virus Res 184:44\u201353. https:\/\/doi.org\/10.1016\/j.virusres.2014.02.010","DOI":"10.1016\/j.virusres.2014.02.010"},{"key":"11115_CR7","doi-asserted-by":"publisher","unstructured":"Chatterji U, Bobardt M, Tai A, Wood M, Gallay PA (2015) Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factories. Antimicrob Agents Chemother 59(5):2496\u20132507. https:\/\/doi.org\/10.1128\/aac.04958-14","DOI":"10.1128\/aac.04958-14"},{"key":"11115_CR8","doi-asserted-by":"publisher","unstructured":"Chatterji U, Bobardt M, Schaffer L, Wood M, Gallay PA (2016) Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection. PLoS One 11(7):e0159511. https:\/\/doi.org\/10.1371\/journal.pone.0159511","DOI":"10.1371\/journal.pone.0159511"},{"key":"11115_CR9","doi-asserted-by":"publisher","unstructured":"Cortines JR, Lima LM, Mohana-Borges R, Millen Tde A, Gaspar LP, Lanman JK, Prevelige PE Jr, Silva JL (2015) Structural insights into the stabilization of the human immunodeficiency virus type 1 capsid protein by the cyclophilin-binding domain and implications on the virus cycle. Biochim Biophys Acta 1854(5):341\u2013348. https:\/\/doi.org\/10.1016\/j.bbapap.2014.12.008","DOI":"10.1016\/j.bbapap.2014.12.008"},{"key":"11115_CR10","doi-asserted-by":"publisher","unstructured":"De Iaco A, Luban J (2014) Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA. Retrovirology 11:11. https:\/\/doi.org\/10.1186\/1742-4690-11-11","DOI":"10.1186\/1742-4690-11-11"},{"key":"11115_CR11","doi-asserted-by":"publisher","unstructured":"de Wilde AH, Li Y, van der Meer Y, Vuagniaux G, Lysek R, Fang Y, Snijder EJ, van Hemert MJ (2013) Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis. J Virol 87(3):1454\u20131464. https:\/\/doi.org\/10.1128\/JVI.02078-12","DOI":"10.1128\/JVI.02078-12"},{"key":"11115_CR12","doi-asserted-by":"publisher","unstructured":"de Wilde AH, Pham U, Posthuma CC, Snijder EJ (2018a) Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology 522:46\u201355. https:\/\/doi.org\/10.1016\/j.virol.2018.06.011","DOI":"10.1016\/j.virol.2018.06.011"},{"key":"11115_CR13","doi-asserted-by":"publisher","unstructured":"de Wilde AH, Zevenhoven-Dobbe JC, Beugeling C, Chatterji U, de Jong D, Gallay P, Szuhai K, Posthuma CC, Snijder EJ (2018b) Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture. Virology 517:148\u2013156. https:\/\/doi.org\/10.1016\/j.virol.2017.11.022","DOI":"10.1016\/j.virol.2017.11.022"},{"key":"11115_CR14","doi-asserted-by":"publisher","unstructured":"Deng XY, Dai P, Yu MJ, Chen LS, Zhu CM, You XX, Li LL, Zeng YH (2018) Cyclophilin A is the potential receptor of the Mycoplasma genitalium adhesion protein. Int J Med Microbiol 308(3):405\u2013412. https:\/\/doi.org\/10.1016\/j.ijmm.2018.03.001","DOI":"10.1016\/j.ijmm.2018.03.001"},{"key":"11115_CR15","doi-asserted-by":"publisher","unstructured":"Dhanda AS, Warren KE, Chiu RH, Guttman JA (2018) Cyclophilin A Controls Salmonella Internalization Levels and is Present at E. coli Actin-Rich Pedestals. Anat Rec (Hoboken) 301(12):2086\u20132094. https:\/\/doi.org\/10.1002\/ar.23957","DOI":"10.1002\/ar.23957"},{"key":"11115_CR16","doi-asserted-by":"publisher","unstructured":"Dmochewitz L, Lillich M, Kaiser E, Jennings LD, Lang AE, Buchner J, Fischer G, Aktories K, Collier RJ, Barth H (2011) Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigen. Cell Microbiol 13(3):359\u2013373. https:\/\/doi.org\/10.1111\/j.1462-5822.2010.01539.x","DOI":"10.1111\/j.1462-5822.2010.01539.x"},{"key":"11115_CR17","doi-asserted-by":"publisher","unstructured":"Donahue DA, Amraoui S, di Nunzio F, Kieffer C, Porrot F, Opp S, Diaz-Griffero F, Casartelli N, Schwartz O (2016) SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV. J Virol 90(8):4199\u20134214. https:\/\/doi.org\/10.1128\/JVI.03202-15","DOI":"10.1128\/JVI.03202-15"},{"key":"11115_CR18","doi-asserted-by":"publisher","unstructured":"Donahue DA, Porrot F, Couespel N, Schwartz O (2017) SUN2 Silencing Impairs CD4 T Cell Proliferation and Alters Sensitivity to HIV-1 Infection Independently of Cyclophilin A. J Virol 91(6). https:\/\/doi.org\/10.1128\/jvi.02303-16","DOI":"10.1128\/jvi.02303-16"},{"key":"11115_CR19","doi-asserted-by":"publisher","unstructured":"Dujardin M, Madan V, Gandhi NS, Cantrelle FX, Launay H, Huvent I, Bartenschlager R, Lippens G, Hanoulle X (2019) Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication. J Biol Chem 294(35):13171\u201313185. https:\/\/doi.org\/10.1074\/jbc.RA119.009537","DOI":"10.1074\/jbc.RA119.009537"},{"key":"11115_CR20","doi-asserted-by":"publisher","unstructured":"Dutta M, Delhi P, Sinha KM, Banerjee R, Datta AK (2001) Lack of abundance of cytoplasmic cyclosporin A-binding protein renders free-living Leishmania donovani resistant to cyclosporin A. J Biol Chem 276(22):19294\u201319300. https:\/\/doi.org\/10.1074\/jbc.M009379200","DOI":"10.1074\/jbc.M009379200"},{"key":"11115_CR21","doi-asserted-by":"publisher","unstructured":"Eyre NS, Beard MR (2014) HCV NS5A inhibitors disrupt replication factory formation: a novel mechanism of antiviral action. Gastroenterology 147(5):959\u2013962. https:\/\/doi.org\/10.1053\/j.gastro.2014.09.024","DOI":"10.1053\/j.gastro.2014.09.024"},{"key":"11115_CR22","doi-asserted-by":"publisher","unstructured":"Gallay PA, Ptak RG, Bobardt MD, Dumont JM, Vuagniaux G, Rosenwirth B (2013) Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms. Viruses 5(3):981\u2013997. https:\/\/doi.org\/10.3390\/v5030981","DOI":"10.3390\/v5030981"},{"key":"11115_CR23","doi-asserted-by":"publisher","unstructured":"Gallay PA, Bobardt MD, Chatterji U, Trepanier DJ, Ure D, Ordonez C, Foster R (2015) The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action. PLoS One 10(8):e0134707. https:\/\/doi.org\/10.1371\/journal.pone.0134707","DOI":"10.1371\/journal.pone.0134707"},{"key":"11115_CR24","doi-asserted-by":"publisher","unstructured":"Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP (1996) Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87(7):1285\u20131294. https:\/\/doi.org\/10.1016\/s0092-8674(00)81823-1","DOI":"10.1016\/s0092-8674(00)81823-1"},{"key":"11115_CR25","doi-asserted-by":"publisher","unstructured":"Han J, Lee HW, Jin Y, Khadka DB, Yang S, Li X, Kim M, Cho WJ (2020) Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment. Eur J Med Chem 188:112031. https:\/\/doi.org\/10.1016\/j.ejmech.2019.112031","DOI":"10.1016\/j.ejmech.2019.112031"},{"key":"11115_CR26","doi-asserted-by":"publisher","unstructured":"Harikishore A, Yoon HS (2015) Immunophilins: Structures, Mechanisms and Ligands. Curr Mol Pharmacol 9(1):37\u201347. https:\/\/doi.org\/10.2174\/1874467208666150519113427","DOI":"10.2174\/1874467208666150519113427"},{"key":"11115_CR27","doi-asserted-by":"publisher","unstructured":"He H, Zhou D, Fan W, Fu X, Zhang J, Shen Z, Li J, Li J, Wu Y (2012) Cyclophilin A inhibits rotavirus replication by facilitating host IFN-I production. Biochem Biophys Res Commun 422(4):664\u2013669. https:\/\/doi.org\/10.1016\/j.bbrc.2012.05.050","DOI":"10.1016\/j.bbrc.2012.05.050"},{"key":"11115_CR28","doi-asserted-by":"publisher","unstructured":"He H, Mou Z, Li W, Fei L, Tang Y, Zhang J, Yan P, Chen Z, Yang X, Shen Z, Li J, Wu Y (2013) Proteomic methods reveal cyclophilin A function as a host restriction factor against rotavirus infection. Proteomics 13(7):1121\u20131132. https:\/\/doi.org\/10.1002\/pmic.201100579","DOI":"10.1002\/pmic.201100579"},{"key":"11115_CR29","doi-asserted-by":"publisher","unstructured":"Hoerauf A, Rascher C, Bang R, Pahl A, Solbach W, Brune K, R\u00f6llinghoff M, Bang H (1997) Host-cell cyclophilin is important for the intracellular replication of Leishmania major. Mol Microbiol 24(2):421\u2013429. https:\/\/doi.org\/10.1046\/j.1365-2958.1997.3401716.x","DOI":"10.1046\/j.1365-2958.1997.3401716.x"},{"key":"11115_CR30","doi-asserted-by":"publisher","unstructured":"Hou J, Zhang Q, Liu Z, Wang S, Li D, Liu C, Liu Y, Shao Y (2016) Cyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice. Hum Vaccin Immunother 12(2):545\u2013553. https:\/\/doi.org\/10.1080\/21645515.2015.1082692","DOI":"10.1080\/21645515.2015.1082692"},{"key":"11115_CR31","doi-asserted-by":"publisher","unstructured":"Jiang J, Yin HL, Sun Y, Huang HQ, Hu XC (2018) Clonorchis sinensis cyclophilin A immunization protected mice from CLP-induced sepsis. Int Immunopharmacol 59:347\u2013353. https:\/\/doi.org\/10.1016\/j.intimp.2018.03.039","DOI":"10.1016\/j.intimp.2018.03.039"},{"key":"11115_CR32","doi-asserted-by":"publisher","unstructured":"Jimenez-Guarde\u00f1o JM, Apolonia L, Betancor G, Malim MH (2019) Immunoproteasome activation enables human TRIM5\u03b1 restriction of HIV-1. Nat Microbiol 4(6):933\u2013940. https:\/\/doi.org\/10.1038\/s41564-019-0402-0","DOI":"10.1038\/s41564-019-0402-0"},{"key":"11115_CR33","doi-asserted-by":"publisher","unstructured":"Jyothi KR, Beloor J, Jo A, Nguyen MN, Choi TG, Kim JH, Akter S, Lee SK, Maeng CH, Baik HH, Kang I, Ha J, Kim SS (2015) Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication. Int J Nanomedicine 10:903\u2013921. https:\/\/doi.org\/10.2147\/IJN.S74723","DOI":"10.2147\/IJN.S74723"},{"key":"11115_CR34","doi-asserted-by":"publisher","unstructured":"Kaiser E, Kroll C, Ernst K, Schwan C, Popoff M, Fischer G, Buchner J, Aktories K, Barth H (2011) Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90. Infect Immun 79(10):3913\u20133921. https:\/\/doi.org\/10.1128\/iai.05372-11","DOI":"10.1128\/iai.05372-11"},{"key":"11115_CR35","doi-asserted-by":"publisher","unstructured":"Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441(7089):101\u2013105. https:\/\/doi.org\/10.1038\/nature04734","DOI":"10.1038\/nature04734"},{"key":"11115_CR36","doi-asserted-by":"publisher","unstructured":"Keyes LR, Bego MG, Soland M, St Jeor S (2012) Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation. J Gen Virol 93(Pt 4):722\u2013732. https:\/\/doi.org\/10.1099\/vir.0.037309-0","DOI":"10.1099\/vir.0.037309-0"},{"key":"11115_CR37","doi-asserted-by":"publisher","unstructured":"Kim K, Dauphin A, Komurlu S, McCauley SM, Yurkovetskiy L, Carbone C, Diehl WE, Strambio-De-Castillia C, Campbell EM, Luban J (2019) Cyclophilin A protects HIV-1 from restriction by human TRIM5\u03b1. Nat Microbiol 4(12):2044\u20132051. https:\/\/doi.org\/10.1038\/s41564-019-0592-5","DOI":"10.1038\/s41564-019-0592-5"},{"key":"11115_CR38","doi-asserted-by":"publisher","unstructured":"Kovalev N, Nagy PD (2013) Cyclophilin A Binds to the Viral RNA and Replication Proteins, Resulting in Inhibition of Tombusviral Replicase Assembly. J Virol 87(24):13330\u201313342. https:\/\/doi.org\/10.1128\/Jvi.02101-13","DOI":"10.1128\/Jvi.02101-13"},{"key":"11115_CR39","doi-asserted-by":"publisher","unstructured":"Krucken J, Greif G, von Samson-Himmelstjerna G (2009) In silico analysis of the cyclophilin repertoire of apicomplexan parasites. Parasit Vectors 2(1):27. https:\/\/doi.org\/10.1186\/1756-3305-2-27","DOI":"10.1186\/1756-3305-2-27"},{"key":"11115_CR40","doi-asserted-by":"publisher","unstructured":"Lahaye X, Satoh T, Gentili M, Cerboni S, Silvin A, Conrad C, Ahmed-Belkacem A, Rodriguez EC, Guichou JF, Bosquet N, Piel M, Le Grand R, King MC, Pawlotsky JM, Manel N (2016) Nuclear Envelope Protein SUN2 Promotes Cyclophilin-A-Dependent Steps of HIV Replication. Cell Rep 15(4):879\u2013892. https:\/\/doi.org\/10.1016\/j.celrep.2016.03.074","DOI":"10.1016\/j.celrep.2016.03.074"},{"key":"11115_CR41","doi-asserted-by":"publisher","unstructured":"Li Y, Kar AK, Sodroski J (2009) Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. J Virol 83(21):10951\u201310962. https:\/\/doi.org\/10.1128\/JVI.00682-09","DOI":"10.1128\/JVI.00682-09"},{"key":"11115_CR42","doi-asserted-by":"publisher","unstructured":"Li L, Luo D, Liao Y, Peng K, Zeng Y (2020) Mycoplasma genitalium Protein of Adhesion Induces Inflammatory Cytokines via Cyclophilin A-CD147 Activating the ERK-NF-\u03baB Pathway in Human Urothelial Cells. Front Immunol 11:2052. https:\/\/doi.org\/10.3389\/fimmu.2020.02052","DOI":"10.3389\/fimmu.2020.02052"},{"key":"11115_CR43","doi-asserted-by":"publisher","unstructured":"Liu Z, Yang F, Robotham JM, Tang H (2009) Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex. J Virol 83(13):6554\u20136565. https:\/\/doi.org\/10.1128\/JVI.02550-08","DOI":"10.1128\/JVI.02550-08"},{"key":"11115_CR44","doi-asserted-by":"publisher","unstructured":"Liu X, Zhao Z, Li Z, Xu C, Sun L, Chen J, Liu W (2012a) Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways. PLoS One 7(5):e37277. https:\/\/doi.org\/10.1371\/journal.pone.0037277","DOI":"10.1371\/journal.pone.0037277"},{"key":"11115_CR45","doi-asserted-by":"publisher","unstructured":"Liu X, Zhao Z, Xu C, Sun L, Chen J, Zhang L, Liu W (2012b) Cyclophilin A restricts influenza A virus replication through degradation of the M1 protein. PLoS One 7(2):e31063. https:\/\/doi.org\/10.1371\/journal.pone.0031063","DOI":"10.1371\/journal.pone.0031063"},{"key":"11115_CR46","doi-asserted-by":"publisher","unstructured":"Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C (2013) The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14(4):398\u2013410. https:\/\/doi.org\/10.1016\/j.chom.2013.08.015","DOI":"10.1016\/j.chom.2013.08.015"},{"key":"11115_CR47","doi-asserted-by":"publisher","unstructured":"Liu Z, Pan Q, Liang Z, Qiao W, Cen S, Liang C (2015) The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB. Retrovirology 12:1. https:\/\/doi.org\/10.1186\/s12977-014-0129-1","DOI":"10.1186\/s12977-014-0129-1"},{"key":"11115_CR48","doi-asserted-by":"crossref","unstructured":"Liu W, Li J, Zheng W, Shang Y, Zhao Z, Wang S, Bi Y, Zhang S, Xu C, Duan Z (2017) Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses. Elife 6:e24425","DOI":"10.7554\/eLife.24425"},{"key":"11115_CR49","doi-asserted-by":"publisher","unstructured":"Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M Jr (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82(1):335\u2013345. https:\/\/doi.org\/10.1128\/JVI.01080-07","DOI":"10.1128\/JVI.01080-07"},{"key":"11115_CR50","doi-asserted-by":"publisher","unstructured":"Luo X, Yang W, Gao G (2018) SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A. J Virol 92(13):e00229\u2013e00218. https:\/\/doi.org\/10.1128\/jvi.00229-18","DOI":"10.1128\/jvi.00229-18"},{"key":"11115_CR51","doi-asserted-by":"publisher","unstructured":"Ma C, Li F, Musharrafieh RG, Wang J (2016) Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance. Antivir Res 133:62\u201372. https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.019","DOI":"10.1016\/j.antiviral.2016.07.019"},{"key":"11115_CR52","doi-asserted-by":"publisher","unstructured":"Madan V, Paul D, Lohmann V, Bartenschlager R (2014) Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation. Gastroenterology 146(5):1361\u20131372.e1361-1369. https:\/\/doi.org\/10.1053\/j.gastro.2014.01.055","DOI":"10.1053\/j.gastro.2014.01.055"},{"key":"11115_CR53","doi-asserted-by":"publisher","unstructured":"Mahesutihan M, Zheng W, Cui L, Li Y, Jiao P, Yang W, Liu W, Li J, Fan W, Yang L, Liu W (2018) CypA Regulates AIP4-Mediated M1 Ubiquitination of Influenza A Virus. 33(5):440\u2013448. https:\/\/doi.org\/10.1007\/s12250-018-0058-6","DOI":"10.1007\/s12250-018-0058-6"},{"key":"11115_CR54","doi-asserted-by":"publisher","unstructured":"Mahlangu MP, M\u00fcller EE, Venter JME, Maseko DV, Kularatne RS (2019) The Prevalence of Mycoplasma genitalium and Association With Human Immunodeficiency Virus Infection in Symptomatic Patients, Johannesburg, South Africa, 2007-2014. Sex Transm Dis 46(6):395\u2013399. https:\/\/doi.org\/10.1097\/olq.0000000000000984","DOI":"10.1097\/olq.0000000000000984"},{"key":"11115_CR55","doi-asserted-by":"publisher","unstructured":"Ma-Lauer Y, Zheng Y, Male\u0161evi\u0107 M, von Brunn B, Fischer G, von Brunn A, Center G (2019) Interaction of cyclophilin A and human coronavirus 229E N protein is essential for virus replication. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104620","DOI":"10.1016\/j.antiviral.2019.104620"},{"key":"11115_CR56","doi-asserted-by":"publisher","unstructured":"Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, Littman DR (2010) A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467(7312):214\u2013217. https:\/\/doi.org\/10.1038\/nature09337","DOI":"10.1038\/nature09337"},{"key":"11115_CR57","doi-asserted-by":"publisher","unstructured":"Meehan AM, Saenz DT, Guevera R, Morrison JH, Peretz M, Fadel HJ, Hamada M, van Deursen J, Poeschla EM (2014) A cyclophilin homology domain-independent role for Nup358 in HIV-1 infection. PLoS Pathog 10(2):e1003969. https:\/\/doi.org\/10.1371\/journal.ppat.1003969","DOI":"10.1371\/journal.ppat.1003969"},{"key":"11115_CR58","doi-asserted-by":"publisher","unstructured":"Neuman BW, Joseph JS, Saikatendu KS, Serrano P, Chatterjee A, Johnson MA, Liao L, Klaus JP, Yates JR 3rd, Wuthrich K, Stevens RC, Buchmeier MJ, Kuhn P (2008) Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J Virol 82(11):5279\u20135294. https:\/\/doi.org\/10.1128\/JVI.02631-07","DOI":"10.1128\/JVI.02631-07"},{"key":"11115_CR59","doi-asserted-by":"publisher","unstructured":"Nevers Q, Ruiz I, Ahnou N, Donati F, Brillet R, Softic L, Chazal M, Jouvenet N, Fourati S, Baudesson C, Bruscella P, Gelin M, Guichou JF, Pawlotsky JM, Ahmed-Belkacem A (2018) Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity. Antimicrob Agents Chemother 62(7):e00126\u2013e00118. https:\/\/doi.org\/10.1128\/aac.00126-18","DOI":"10.1128\/aac.00126-18"},{"key":"11115_CR60","doi-asserted-by":"publisher","unstructured":"Ngure M, Issur M, Shkriabai N, Liu HW, Cosa G, Kvaratskhelia M, G\u00f6tte M (2016) Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap. ACS Infect Dis 2(11):839\u2013851. https:\/\/doi.org\/10.1021\/acsinfecdis.6b00143","DOI":"10.1021\/acsinfecdis.6b00143"},{"key":"11115_CR61","doi-asserted-by":"publisher","unstructured":"Nigro P, Pompilio G, Capogrossi MC (2013) Cyclophilin A: a key player for human disease. Cell Death Dis 4(10):e888. https:\/\/doi.org\/10.1038\/cddis.2013.410","DOI":"10.1038\/cddis.2013.410"},{"key":"11115_CR62","doi-asserted-by":"publisher","unstructured":"Pell\u00e9 R, McOdimba F, Chuma F, Wasawo D, Pearson TW, Murphy NB (2002) The African trypanosome cyclophilin A homologue contains unusual conserved central and N-terminal domains and is developmentally regulated. Gene 290(1-2):181\u2013191. https:\/\/doi.org\/10.1016\/s0378-1119(02)00559-0","DOI":"10.1016\/s0378-1119(02)00559-0"},{"key":"11115_CR63","doi-asserted-by":"publisher","unstructured":"Pfefferle S, Sch\u00f6pf J, K\u00f6gl M, Friedel CC, M\u00fcller MA, Carbajo-Lozoya J, Stellberger T, von Dall'Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Z\u00fcst R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann-Wessels C, P\u00f6hlmann S, Haas J, Drosten C, von Brunn A (2011) The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog 7(10):e1002331. https:\/\/doi.org\/10.1371\/journal.ppat.1002331","DOI":"10.1371\/journal.ppat.1002331"},{"key":"11115_CR64","doi-asserted-by":"publisher","unstructured":"Phillips S, Chokshi S, Chatterji U, Riva A, Bobardt M, Williams R, Gallay P, Naoumov NV (2015) Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production. Gastroenterology 148(2):403\u2013414.e407. https:\/\/doi.org\/10.1053\/j.gastro.2014.10.004","DOI":"10.1053\/j.gastro.2014.10.004"},{"key":"11115_CR65","doi-asserted-by":"publisher","unstructured":"Potenza M, Galat A, Minning TA, Ruiz AM, Duran R, Tarleton RL, Marin M, Fichera LE, Bua J (2006) Analysis of the Trypanosoma cruzi cyclophilin gene family and identification of Cyclosporin A binding proteins. Parasitology 132(Pt 6):867\u2013882. https:\/\/doi.org\/10.1017\/S0031182005009558","DOI":"10.1017\/S0031182005009558"},{"key":"11115_CR66","doi-asserted-by":"publisher","unstructured":"Qian Z, Yue W, Li B (2010) Progress of CypA and lung cancer-related research. Zhongguo Fei Ai Za Zhi 13(8):827\u2013831. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2010.08.15","DOI":"10.3779\/j.issn.1009-3419.2010.08.15"},{"key":"11115_CR67","doi-asserted-by":"publisher","unstructured":"Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, Su D, Ni C, Li J, Rao Z, Liu L, Lou Z (2014) Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog 10(10):e1004422. https:\/\/doi.org\/10.1371\/journal.ppat.1004422","DOI":"10.1371\/journal.ppat.1004422"},{"key":"11115_CR68","doi-asserted-by":"publisher","unstructured":"Reddy SP, Rasmussen WG, Baseman JB (1996) Correlations between Mycoplasma pneumoniae sensitivity to cyclosporin A and cyclophilin-mediated regulation of mycoplasma cytadherence. Microb Pathog 20(3):155\u2013169. https:\/\/doi.org\/10.1006\/mpat.1996.0014","DOI":"10.1006\/mpat.1996.0014"},{"key":"11115_CR69","doi-asserted-by":"publisher","unstructured":"Reghellin V, Donnici L, Fenu S, Berno V, Calabrese V, Pagani M, Abrignani S, Peri F, De Francesco R, Neddermann P (2014) NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIalpha complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes. Antimicrob Agents Chemother 58(12):7128\u20137140. https:\/\/doi.org\/10.1128\/aac.03293-14","DOI":"10.1128\/aac.03293-14"},{"key":"11115_CR70","doi-asserted-by":"publisher","unstructured":"Saleh T, Jankowski W, Sriram G, Rossi P, Shah S, Lee KB, Cruz LA, Rodriguez AJ, Birge RB, Kalodimos CG (2016) Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway. Nat Chem Biol 12(2):117\u2013123. https:\/\/doi.org\/10.1038\/nchembio.1981","DOI":"10.1038\/nchembio.1981"},{"key":"11115_CR71","doi-asserted-by":"publisher","unstructured":"Selyutina A, Persaud M, Simons LM, Bulnes-Ramos A, Buffone C, Martinez-Lopez A, Scoca V, Di Nunzio F, Hiatt J, Marson A, Krogan NJ, Hultquist JF, Diaz-Griffero F (2020) Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5\u03b1 Binding to the Viral Core. Cell Rep 30(11):3766\u20133777.e3766. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.100","DOI":"10.1016\/j.celrep.2020.02.100"},{"key":"11115_CR72","doi-asserted-by":"publisher","unstructured":"Setiawan LC, van Dort KA, Rits MA, Kootstra NA (2016) Mutations in CypA Binding Region of HIV-1 Capsid Affect Capsid Stability and Viral Replication in Primary Macrophages. AIDS Res Hum Retrovir 32(4):390\u2013398. https:\/\/doi.org\/10.1089\/AID.2014.0361","DOI":"10.1089\/AID.2014.0361"},{"key":"11115_CR73","doi-asserted-by":"publisher","unstructured":"Shanmugam S, Nichols AK, Saravanabalaji D, Welsch C, Yi M (2018) HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A. PLoS Pathog 14(7):e1007177. https:\/\/doi.org\/10.1371\/journal.ppat.1007177","DOI":"10.1371\/journal.ppat.1007177"},{"key":"11115_CR74","volume-title":"Molecular virology and control of flaviviruses","author":"P-Y Shi","year":"2012","unstructured":"Shi P-Y (2012) Molecular virology and control of flaviviruses, vol 7. Caister Academic Press, Norfolk"},{"key":"11115_CR75","doi-asserted-by":"publisher","unstructured":"Softic L, Brillet R, Berry F, Ahnou N, Nevers Q, Morin-Dewaele M, Hamadat S, Bruscella P, Fourati S, Pawlotsky JM, Ahmed-Belkacem A (2020) Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025). Antimicrob Agents Chemother 64(7). https:\/\/doi.org\/10.1128\/AAC.00876-20","DOI":"10.1128\/AAC.00876-20"},{"key":"11115_CR76","doi-asserted-by":"publisher","unstructured":"Song T, Yang M, Chen J, Huang L, Yin H, He T, Huang H, Hu X (2015) Prognosis of sepsis induced by cecal ligation and puncture in mice improved by anti-Clonorchis Sinensis cyclopholin a antibodies. Parasit Vectors 8:502. https:\/\/doi.org\/10.1186\/s13071-015-1111-z","DOI":"10.1186\/s13071-015-1111-z"},{"key":"11115_CR77","doi-asserted-by":"publisher","unstructured":"Suzuki T, Aizaki H, Murakami K, Shoji I, Wakita T (2007) Molecular biology of hepatitis C virus. J Gastroenterol 42(6):411\u2013423. https:\/\/doi.org\/10.1007\/s00535-007-2030-3","DOI":"10.1007\/s00535-007-2030-3"},{"key":"11115_CR78","doi-asserted-by":"publisher","unstructured":"Tian X, Zhao C, Zhu H, She W, Zhang J, Liu J, Li L, Zheng S, Wen YM, Xie Y (2010) Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection. J Virol 84(7):3373\u20133381. https:\/\/doi.org\/10.1128\/JVI.02555-09","DOI":"10.1128\/JVI.02555-09"},{"key":"11115_CR79","doi-asserted-by":"publisher","unstructured":"Valiente-Echeverria F, Melnychuk L, Vyboh K, Ajamian L, Gallouzi IE, Bernard N, Mouland AJ (2014) eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection. Nat Commun 5:4819. https:\/\/doi.org\/10.1038\/ncomms5819","DOI":"10.1038\/ncomms5819"},{"key":"11115_CR80","doi-asserted-by":"publisher","unstructured":"Vidotto A, Morais AT, Ribeiro MR, Pacca CC, Terzian AC, Gil LH, Mohana-Borges R, Gallay P, Nogueira ML (2017) Systems Biology Reveals NS4B-Cyclophilin A Interaction: A New Target to Inhibit YFV Replication. J Proteome Res 16(4):1542\u20131555. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00933","DOI":"10.1021\/acs.jproteome.6b00933"},{"key":"11115_CR81","doi-asserted-by":"publisher","unstructured":"Yi DR, An N, Liu ZL, Xu FW, Raniga K, Li QJ, Zhou R, Wang J, Zhang YX, Zhou JM, Zhang LL, An J, Qin CF, Guo F, Li XY, Liang C, Cen S (2019) Human MxB Inhibits the Replication of Hepatitis C Virus. J Virol 93(1). https:\/\/doi.org\/10.1128\/JVI.01285-18","DOI":"10.1128\/JVI.01285-18"},{"key":"11115_CR82","doi-asserted-by":"publisher","unstructured":"Zeuzem S, Flisiak R, Vierling JM, Mazur W, Mazzella G, Thongsawat S, Abdurakhmanov D, Van Kinh N, Calistru P, Heo J, Stanciu C, Gould M, Makara M, Hsu SJ, Buggisch P, Samuel D, Mutimer D, Nault B, Merz M, Bao W, Griffel LH, Brass C, Naoumov NV, Grp EIS (2015) Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II). Aliment Pharmacol Ther 42(7):829\u2013844. https:\/\/doi.org\/10.1111\/apt.13342","DOI":"10.1111\/apt.13342"},{"key":"11115_CR83","doi-asserted-by":"publisher","unstructured":"Zhao C, Fang CY, Tian XC, Wang L, Yang PY, Wen YM (2007) Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A. J Med Virol 79(10):1478\u20131484. https:\/\/doi.org\/10.1002\/jmv.20945","DOI":"10.1002\/jmv.20945"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-021-11115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-021-11115-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-021-11115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:53:18Z","timestamp":1744152798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-021-11115-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["11115"],"URL":"https:\/\/doi.org\/10.1007\/s00253-021-11115-2","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"12 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}